In addition, overexpression of TFCP2L1 and CDK1 in T24 cells increased clonogenic activity in a clonogenic limiting dilution assay (Fig 5H), confirming the importance of CDK1‐TFCP2L1 pathways for the stemness features of BC cells. The gene discussed is TFCP2L1; the disease is breast cancer.